---
title: "Silex Systems Options Lapse, Slightly Streamlining Capital Structure"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280260182.md"
description: "Silex Systems Options Lapse, Slightly Streamlining Capital Structure"
datetime: "2026-03-24T05:28:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280260182.md)
  - [en](https://longbridge.com/en/news/280260182.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280260182.md)
generator: "portal-rs"
---

# Silex Systems Options Lapse, Slightly Streamlining Capital Structure

Silex Systems Options Lapse, Slightly Streamlining Capital Structure

### Related Stocks

- [SLXN.US](https://longbridge.com/en/quote/SLXN.US.md)
- [SST.US](https://longbridge.com/en/quote/SST.US.md)
- [IXJ.AU](https://longbridge.com/en/quote/IXJ.AU.md)
- [SLX.AU](https://longbridge.com/en/quote/SLX.AU.md)

## Related News & Research

- [MapQuest Tops the Charts at No. 1 Overall Free App in the U.S. and Canada Apple App Stores | SST Stock News](https://longbridge.com/en/news/297674648.md)
- [SLX: SILEX laser enrichment advances toward US commercialisation, targeting major nuclear fuel market gaps](https://longbridge.com/en/news/297095923.md)
- [After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)](https://longbridge.com/en/news/296918567.md)
- [Silexion Therapeutics publishes corporate deck spotlighting SIL204 siRNA program targeting KRAS-driven cancers](https://longbridge.com/en/news/295325850.md)
- [System1 Reports Q2 Revenue Amid Ongoing Operating Losses](https://longbridge.com/en/news/295022134.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**